ES2157107T3 - Uso de moxonidina para el tratamiento del dolor neuropatico. - Google Patents

Uso de moxonidina para el tratamiento del dolor neuropatico.

Info

Publication number
ES2157107T3
ES2157107T3 ES98117344T ES98117344T ES2157107T3 ES 2157107 T3 ES2157107 T3 ES 2157107T3 ES 98117344 T ES98117344 T ES 98117344T ES 98117344 T ES98117344 T ES 98117344T ES 2157107 T3 ES2157107 T3 ES 2157107T3
Authority
ES
Spain
Prior art keywords
moxonidine
treatment
neuropathic pain
composition
pharmaceutically acceptable
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES98117344T
Other languages
English (en)
Inventor
Carolyn A Fairbanks
George L Wilcox
Tinna M Laughlin
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Abbott Products GmbH
Original Assignee
Solvay Pharmaceuticals GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Solvay Pharmaceuticals GmbH filed Critical Solvay Pharmaceuticals GmbH
Application granted granted Critical
Publication of ES2157107T3 publication Critical patent/ES2157107T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

UN PROCEDIMIENTO PARA ALIVIAR EL DOLOR NEUROPATICO UTILIZA MOXONIDINA Y SUS SALES ACIDAS DE ADICION FISIOLOGICAMENTE COMPATIBLES PARA EL TRATAMIENTO Y/O LA PROFILAXIS DEL DOLOR NEUROPATICO. A UN SUJETO QUE NECESITE DICHO TRATAMIENTO, SE LE ADMINISTRA UNA COMPOSICION QUE COMPRENDE UNA CANTIDAD EFECTIVA DE MOXONIDINA Y UNA SAL FARMACEUTICAMENTE ACEPTABLE DE LA MISMA, EN UN VEHICULO FARMACEUTICAMENTE ACEPTABLE. LA COMPOSICION PUEDE ADMINISTRARSE INTRATECALMENTE.
ES98117344T 1997-09-16 1998-09-14 Uso de moxonidina para el tratamiento del dolor neuropatico. Expired - Lifetime ES2157107T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US5902197P 1997-09-16 1997-09-16

Publications (1)

Publication Number Publication Date
ES2157107T3 true ES2157107T3 (es) 2001-08-01

Family

ID=22020310

Family Applications (1)

Application Number Title Priority Date Filing Date
ES98117344T Expired - Lifetime ES2157107T3 (es) 1997-09-16 1998-09-14 Uso de moxonidina para el tratamiento del dolor neuropatico.

Country Status (8)

Country Link
US (1) US6054461A (es)
EP (1) EP0901790B1 (es)
AT (1) ATE201598T1 (es)
DE (1) DE69800859T2 (es)
DK (1) DK0901790T3 (es)
ES (1) ES2157107T3 (es)
GR (1) GR3036071T3 (es)
PT (1) PT901790E (es)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6559186B1 (en) 1990-02-26 2003-05-06 Arc 1, Inc. Compositions and methods of treatment of sympathetically maintained pain
DE19911371A1 (de) * 1999-03-15 2000-09-21 Solvay Pharm Gmbh Arzneimittel zur Behandlung von funktionellen Störungen und Erkrankungen der unteren Darmwege, insbesondere von damit einhergehenden abdominalen visceralen Schmerzen
US7015371B2 (en) * 2001-03-07 2006-03-21 Mary Hannaman Romans Non-traumatic model for neurogenic pain
US20040048874A1 (en) * 2001-05-22 2004-03-11 Bardsley Hazel Judith New therapeutic use of 4-(2-fluorophenyl)-6-methyl-2-(1-piperazinyl)thieno[2,3-D]pyrimidine
GB0216027D0 (en) * 2002-07-10 2002-08-21 Arachnova Therapeutics Ltd New therapeutic use
PL372695A1 (en) * 2002-06-19 2005-07-25 Solvay Pharmaceuticals Gmbh Medicament for the treatment of diseases requiring inhibition or a reduction in the activity of ph value-regulating bicarbonate transporter proteins
AU2004204825B2 (en) * 2003-01-13 2007-07-19 Dynogen Pharmaceuticals, Inc. Method of treating functional bowel disorders
EP1567163B1 (en) * 2003-01-13 2007-04-11 Dynogen Pharmaceuticals Inc. Method of treating nausea, vomiting, retching or any combination thereof
WO2004071424A2 (en) * 2003-02-05 2004-08-26 Teva Pharmaceutical Industries, Ltd. Immediate release formulation of n-(2-propylpentanoyl)glycinamide
EP1626707A4 (en) * 2003-02-05 2009-07-01 Yissum Res Dev Co CONTINUOUSLY RELEASE FORMULA OF N- (2-PROPYLPENTANOYL) GLYCINAMIDE, AND ASSOCIATED COMPOUNDS
US20050038062A1 (en) * 2003-04-14 2005-02-17 Burns Lindsay H. Methods and materials for the treatment of pain comprising opioid antagonists
US20060293309A1 (en) * 2005-03-28 2006-12-28 Dynogen Pharmaceuticals, Inc. Method of treating disorders and conditions using peripherally-restricted antagonists and inhibitors
US8026266B2 (en) 2005-11-08 2011-09-27 Arcion Therapeutics, Inc. Treatment of length dependent neuropathy
WO2007056460A2 (en) * 2005-11-08 2007-05-18 Arcion Therapeutics, Inc. Treatment of length dependent neuropathy
US7964585B2 (en) * 2006-03-14 2011-06-21 Case Western Reserve University Composition and method of treating peripheral neuropathy

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2104873C (en) * 1991-02-26 2000-05-23 James N. Campbell Compositions and methods of treatment of sympathetically maintained pain

Also Published As

Publication number Publication date
EP0901790A1 (en) 1999-03-17
ATE201598T1 (de) 2001-06-15
DK0901790T3 (da) 2001-08-06
GR3036071T3 (en) 2001-09-28
PT901790E (pt) 2001-09-28
EP0901790B1 (en) 2001-05-30
US6054461A (en) 2000-04-25
DE69800859D1 (de) 2001-07-05
DE69800859T2 (de) 2001-09-27

Similar Documents

Publication Publication Date Title
ES2157107T3 (es) Uso de moxonidina para el tratamiento del dolor neuropatico.
HK1003978A1 (en) Composition for the treatment of schizophrenia
MY119403A (en) Novel compounds with analgesic effect.
BR9913932A (pt) Uso de análogos de glp-1 no tratamento de derrame
EP1428821A8 (en) Piperidin-4-yl amines with analgesic effect
ES2092890T3 (es) Aplicacion del riluzol en el tratamiento de la enfermedad de parkinson y de los sindromes de parkinson.
RS49918B (sr) Upotreba glp-1, ili analoga za lečenje infarkta miokarda
MY115662A (en) Novel compounds with analgesic effect
MX9307883A (es) Aplicacion del riluzol en la preparcion de un medicamento para el tratamiento de lesiones neurologicas.
MY118164A (en) Pharmaceutical composition comprising a combination of metformin and fibrate, and its use for the preparation of medicines intended to reduce hyperglycaemia
PT777482E (pt) Composicao de combinacao para utilizacao em doencas imunologicas
ITMI922331A1 (it) Uso di paratormone, suoi frammenti biologicamente attivi e peptidi correlati, per la preparazione di composizioni farmaceutiche utili nella prevenzione e terapia dell'aborto e del parto pretermine ed in generale per il trattamento della gestazione
ES2174337T3 (es) Uso topico de los agonistas opioides kappa para el tratamiento del dolor ocular.
ES2054718T3 (es) El uso de gepirona para la preparacion de una composicion farmaceutica para el tratamiento de la depresion atipica.
ID24184A (id) Obat untuk perawatan disfungsi ereksi
DE69835461D1 (de) Anti-arrhythmische Zusammensetzungen und Behandlungsverfahren
ES2157984T3 (es) Utilizacion de 4'-yodo-4'-desoxidoxorrubicina para el tratamiento de la amidoidosis.
ES2162813T3 (es) Uso de 3,5-diamino-6-(2,3-diclorofenil)-1,2,4-triazina en la preparacion de un farmaco para el tratamiento de ciertos tipos de dolor y edema.
ES2147796T3 (es) Composicion para el tratamiento o la prevencion del herpes.
ES2086536T3 (es) Uso de ketorolaco para el tratamiento de la enfermedad periodontal.
CO5031290A1 (es) Formulacion lo
HU9501218D0 (en) Use of bhap compounds in combination with other non-nucleoside reverse transcriptase inhibitors for the treatment of hiv infection
NZ508292A (en) Treatment of migraine symptoms with ibuprofen and salts thereof
ES2062752T3 (es) Preparado de una sal de oxipurinol en forma oral para el tratamiento de hiperuricemia.
ZA9427B (en) Use of riluzole for promoting restoration following radiation

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 901790

Country of ref document: ES